NOCIL (NOCIL IN) Set for a smooth ride. Rating: BUY CMP: Rs169 TP: Rs270. Avishek Datta

Size: px
Start display at page:

Download "NOCIL (NOCIL IN) Set for a smooth ride. Rating: BUY CMP: Rs169 TP: Rs270. Avishek Datta"

Transcription

1 (NOCIL IN) Rating: BUY CMP: Rs169 TP: Rs270 Set for a smooth ride Avishek Datta avishekdatta@plindia.com

2 Contents Page No. Rubber chemicals- Poised for growth... 4 Rubber chemicals to ride on increased Tyre usage... 4 Tyre industry in a sweet spot... 4 Nocil s performance against global peers... 7 Nocil At an inflexion point Valuation Key risk to our call Story in charts November 29,

3 November 29, 2018 Company Initiation NOCIL (NOCIL IN) Rating: BUY CMP: Rs169 TP: Rs270 Set for a smooth ride Key Financials(Standalone) FY18 FY19E FY20E FY21E Sales (Rs. m) 9,676 11,176 14,669 18,483 EBITDA (Rs. m) 2,629 3,018 3,667 4,621 Margin (%) PAT (Rs. m) 1,689 1,808 2,371 2,968 EPS (Rs.) Gr. (%) DPS (Rs.) Yield (%) RoE (%) RoCE (%) EV/Sales (x) EV/EBITDA (x) PE (x) P/BV (x) Key Data NOCI.BO NOCIL IN 52-W High / Low Rs. 236 / Rs. 139 Sensex / Nifty 36,170 / 10,859 Market Cap Rs. 28 bn / $ 401 m Shares Outstanding 165m 3M Avg. Daily Value Rs m Shareholding Pattern (%) Promoter s Foreign 4.71 Domestic Institution 6.00 Public & Others Promoter Pledge (Rs bn) 1.21 Stock Performance (%) 1M 6M 12M Absolute 11.0 (11.7) (4.0) Relative 4.5 (14.7) (10.8) Avishek Datta avishekdatta@plindia.com We initiate coverage on Nocil with a BUY and a PT of Rs277, based on P/E of 15x FY21E or 8.0x EV/EBIDTA FY21E. Nocil is India s largest manufacturer of rubber chemicals, with over four decades of experience. The company s technical capabilities and reliability has helped develop deep relationship with leading global and domestic tyre players. Nocil s earnings have increased 7x over FY14-18 led by 1) steady demand growth of 12.5% CAGR 2) higher share of specialty grade chemicals 3) benefit from Anti-Dumping Duty. Nocil remains well placed to capitalize on supply disruptions in China which accounts for 70% of global rubber chemicals supplies. Going forward, Nocil plans to double its capacities by H2FY20E to capitalize on domestic tyre industry capex (Rs250bn over the next five years) and global opportunities from disruption in China. Also, US has imposed 10% duty on rubber chemicals imports from China and will add another 15% duty from January This will open new opportunities for Nocil even though some Chinese supplies might be diverted to India. Timely capex to support growth: Nocil remains well placed to capitalize on domestic and international opportunities. Domestic tyre manufacturers have lined up capex of Rs250bn over the next five years (Source: ICRA), given improved demand traction. Anti-dumping duty (ADD) imposed on imports of TBR tyres from China for five years will spur domestic tyre demand. In the international markets, disruption in Chinese supplies will make the company better placed to capitalize on export markets (US$22bn capex by global tyre players by CY21; Source Notch). Accordingly, Nocil s timely capex of Rs4.3bn will double its capacity in stages through H2FY20 and revenues can potentially double in FY21E, given the asset turn of 2x. Tougher environment norms to lift cost structure: China has progressively tightened environment norms over the last few years. This has disrupted supplies for highly polluting chemical industries as they account for over 70% global rubber chemicals. Tightened environment norms have also increased the cost structure; China Sunsine s CY17 environmental protection expense was up 50%YoY to RMB99mn or 3.6% of revenues. We believe the higher cost structure of rubber chemical players is structural and will ease competitive pressure on players like Nocil, going ahead. Closing the gap to global leaders: Nocil s EBITDA margins have increased 17% over FY14-18 led by 1) cost rationalization 2) backward integration post start of new facility at Dahej in FY13 3) higher share of speciality grade chemicals and 4)imposition of anti-dumping duty (ADD) protection (~4% of sales). However, our analysis of Nocil s operating performance vis-à-vis China Sunsine (CS), one of the world s largest rubber chemicals players, suggest that Nocil s operating matrix has steadily improved due to cost optimization and better raw material sourcing and is better placed to compete with global majors. Initiate with a BUY and PT of Rs277. Nocil remains well placed to capitalise on strong downstream demand from tyre markets. Timely capacity, addition, along with healthy margins, will drive earnings at 22% CAGR over FY18-21E. Initiate with BUY and PT of Rs277 based on 15xPER FY21E. Net cash of Rs7.7bn for FY21E and healthy ROEs of 20% provide downside support. November 29,

4 '000 tons NOCIL Rubber chemicals- Poised for growth Rubber chemicals to ride on increased Tyre usage The rubber processing chemicals industry is a play on growth in downstream demand, especially for Tyres. The global rubber markets consumption in CY17 was expected at 28mn MT and has registered a CAGR 3% over CY12-17 (Source: Rubber Statistical Bulletin). Growth of the rubber industry is directly linked to automobile sector as the Tyre industry accounts for 65% of total rubber usage. Other uses of rubber are latex, footwear, conveyor belt, flooring, cycle tubes, medical gloves etc. Tyre industry in a sweet spot Tyres account for two-thirds of rubber chemicals demand. Overall Indian tyre demand has registered CAGR of 5.2% over FY13-18 led by demand in OEMs and replacement segment. For FY18, according to SIAM (Society of Indian Automobile Manufacturers), demand for passenger vehicles increased 7.9%, while commercial vehicles and three-wheelers were up 19.9% and 24.2%, respectively. For FY18, two-wheelers volume was up 14.8%. Growth is, however, set to accelerate to CAGR of 8.3% over FY18-23E, 1) given the strong government focus on infrastructure 2) rising and vehicle demand due to increased consumerism and 3) imposition of anti-dumping duty (ADD) on radial tyre imports from China for five years. Government has proposed ADD on import of radial tyres for trucks and buses from China to provide a level-playing field to domestic manufacturers. The duties range between US$ /ton for a period of five years. Indian tyre demand to grow at 8.3% CAGR over FY18-23 Replacement OEM FY13 FY14 FY15 FY16 FY17 FY18 FY23F Source: Notch, Crisil, PL November 29,

5 Global tyre demand to accelerate Tyre demand is expected to accelerate globally across segments - passenger and trucks and buses due to favourable demand traction. Overall global demand is also likely to accelerate to 3.3% over CY16-21E against 2.2% over CY Also, global capital expenditure is pegged at US$21.8bn during CY16-21E, given improved demand environment Global tyre demand to accelerate Passenger Trucks & Buses Total CY06-16 CY16-21 Global tyre industry capex at US22bn Asia 9,869 North America 6,319 Europe 3,550 Africa/ME 1,934 South America 150 World 21,822 Source: Notch, Crisil, PL Source: Notch, Crisil, PL Rising environmental cost in China augurs well for rubber chemicals China has progressively tightened environment norms over the last few years. This has resulted in major disruption in supplies for highly polluting chemical industries as they account for over 70% global rubber chemicals. Increased compliance audits have, led to closure of smaller/unorganized units. This has led to disruption in supplies, which in turn, has wide ramifications for downstream users globally. Rising compliance costs among Chinese players has also increased the cost structure. Our analysis of CS (one of the largest rubber chemicals company based out of China) financials suggests that environmental protection expenses for CY17 was up 50%YoY to RMB99mn. This translated to 3.6% of CY17 revenues, up from RMB66mn in CY16 or 3.2% of CY16 revenues. This has meant that companies like Nocil, which are compliant with respect to environmental norms have benefitted immensely-nocil s operating profits more than doubled over FY15 to Rs2.6bn in FY18. Anti-dumping duty on rubber chemicals - an added support Government has levied anti-dumping duty (ADD) on six products out of twenty manufactured by Nocil, which will be effective until July According to Nocil s management, duty protection accounts for 4% of sales and ~35% revenues are exposed to duty protection. With significant over capacity in China, the management is hopeful of ADD duty extension as there is a scope of significant injury to domestic industry from cheaper imports. However, effects of duty protection are overstated as competitors cut prices to compete with domestic players. Accordingly, we have factored in 2% EBITDA margin compression in FY20E to 25% against 27% factored in FY19E. Our sensitivity analysis suggests that if the EBIDTA margins were to erode by 4% (vs 2% in base case), Nocil s FY20E earnings impact will be 8% (pls see the later pages on sensitivity analysis for details). November 29,

6 US imposition of import duty on Chinese imports will open new market US has recently imposed 10% import duty on Chinese rubber chemicals and will add another 15% effective 1 st January US and European markets account for ~22% share and any restrictions on Chinese imports will open up opportunities for other including Nocil. While some of the Chinese supplies might be diverted to India (5% of global market), entry into US will be a high growth opportunity for Nocil. Winds of change blowing across rubber chemicals Rubber chemicals are important additives, which are needed to make simple rubber polymer commercially useful for final applications. By weight, they account for 6%, while they account for 3% of value of rubber. Global rubber chemicals demand is estimated at ~1.2MTPA. There are wide range of rubber-processing chemicals like anti-degradants, accelerators and other processing aids. Anti-degradants: Anti-degradants are chemicals used to develop rubber s resistance to heat, oxidation, sunlight and mechanical stress. It ensures that rubber doesn t split or destroys from friction with road. Accelerators: Accelerators are chemical compounds that speed the process of vulcanization. Vulcanization is one of the major activities on raw rubber to eliminate its sticky nature. Vulcanization process generally takes 45 hours; however, with use of accelerators, the process can be completed in 1 hour. Processing aids: Processing aids act as agents to improve manufacturing process of rubber-based products. Rubber chemicals usage Accelerators 1.7% Vulcanizing agents 2.0% Anti-oxidants 2.2% Source: PL, Industry Rubber 94.1% November 29,

7 Nocil s performance against global peers Given that there are very few listed pure rubber chemicals players globally, we compared Nocil s financials with China Sunsine (one of the world s largest rubber chemicals manufacturers; Mkt cap USD470m). Our detailed comparative analysis over last decade shows many interesting data points which augurs well for Nocil. Sales volume growth: Over the last decade, CS volume has registered CAGR growth of 18% to 140,476MT against 7% CAGR for Nocil. This higher growth rate was supported by rapid expansion in Chinese vehicle population over last decade. However, the company s volume traction has overtaken CS over the last five years, partly out of low base effect and increased capacities to 13% CAGR against 9% for CS. China Sunsine volume growth over Nocil has come off over last five years Nocil China Sunsine 160, , , ,000 80,000 60,000 40,000 20, , , , ,572 98,345 81,371 60,907 54,275 45,420 30,787 30,932 32,169 21,542 23,413 24,171 24,413 23,436 24,960 36,190 40,714 CY08/FY09 CY09/FY10 CY10/FY11 CY11/FY12 CY12/FY13 CY13/FY14 CY14/FY15 CY15/FY16 CY16/FY17 CY17/FY18 Raw material cost share has come down: Raw material intensity has come down for the industry globally. For CS, raw material share has come down to 60% of sales over CY14-18 against over 70% during CY For Nocil, RMC share has come down to less than 50% over FY15-18 against ~60% over FY Raw material intensity has come down for the sector given benign raw material prices Nocil China sunsine 100% 80% 60% 76% 76% 77% 78% 70% 65% 59% 58% 58% 61% 64% 59% 61% 54% 60% 60% 56% 50% 48% 46% 40% 20% 0% CY08/FY09 CY09/FY10 CY10/FY11 CY11/FY12 CY12/FY13 CY13/FY14 CY14/FY15 CY15/FY16 CY16/FY17 CY17/FY18 Source: Company, Company, PL November 29,

8 Operating costs have diverged: Operating cost structure has increased sharply for CS to average 22% of sales over CY13-18 against ~10% over CY Against that, Nocil s cost has averaged at ~30% over last decade and has come down to 27% for FY18. Rising environmental compliance cost will also push the cost structure of the Chinese peers, thereby, reducing the competitive intensity for Nocil. Operating costs for China Sunsine has doubled, while for Nocil it has come off Nocil China sunsine 35% 30% 25% 20% 15% 30% 14% 31% 31% 32% 31% 31% 30% 30% 30% 25% 25% 19% 21% 13% 27% 19% 10% 5% 6% 8% 8% 0% CY08/FY09 CY09/FY10 CY10/FY11 CY11/FY12 CY12/FY13 CY13/FY14 CY14/FY15 CY15/FY16 CY16/FY17 CY17/FY18, Nocil s operating profit margins increased significantly: Nocil s OPM has increased 170bps over FY14-18 led by better product mix, operational efficiency and higher volumes and has overtaken its Chinese peers in FY18. However, CS margins have historically been higher and have averaged ~20% over last four years. Nocil s operating margins have improved significantly over last four years Nocil China sunsine 30% 27% 25% 20% 15% 10% 5% 16% 17% 16% 15% 11% 11% 11% 7% 4% 9% 12% 10% 21% 20% 19% 19% 19% 16% 21% 0% CY08/FY09 CY09/FY10 CY10/FY11 CY11/FY12 CY12/FY13 CY13/FY14 CY14/FY15 CY15/FY16 CY16/FY17 CY17/FY18, PL November 29,

9 ROE-improving trend: CS historically reported better ROE profile against Nocil. However, improving profitability trend has bridged the gap between players. Nocil ROE has been on an uptrend supported by improving financials Nocil China Sunsine CY09/FY10 CY10/FY11 CY11/FY12 CY12/FY13 CY13/FY14 CY14/FY15 CY15/FY16 CY16/FY17 CY17/FY18 November 29,

10 MT NOCIL Nocil At an inflexion point Nocil is part of Arvind Mafatlal Group companies which is India s largest rubber chemicals company offering one of the largest range of rubber chemicals. The company manufactures accelerators, antioxidants, pre-vulcanize inhibitor and post vulcanise inhibitor. While the accelerators and anitoxidants account for ~45% of product slate, while pre and post vulcanizing inhibitors account for ~10%. Nocil has two plants in Navi Mumbai and Dahej with a rated capacity of 55,000 MT. Led by improved market fundamentals, Nocil is on track to double its capacity by H1FY20. The company caters to all the major customers like Continental, Yokohama, Apollo Tyres, Ceat, MRF etc. Nocil is one of the few companies to stay put in the rubber chemicals business despite intense competition from the Chinese players. The company s business fortune got a significant lift post FY14 led by 1) start of modern complex at Dahej 2) imposition of ADD on certain rubber chemicals and 3) tightening environmental norms in China. Timely capacity expansion to meet rising demand Nocil is currently operating at near-rated capacity and plans to spend Rs4.25bn to double its capacity at both the facilities in Navi Mumbai (42,000 tons) and Dahej (11,000 tons). Capacity expansion will be funded largely through internal accruals and all three phases will come on stream by H1FY20E. The first phase of expansion has already come on stream in Q1FY19. With asset turn of 2x, management expects revenues to double post completion of these expansion projects. Nocil capacity to double in stages by H1FY20E 1,20,000 1,10,000 1,00,000 80,000 60,000 55,000 59,400 75,900 80,300 40,000 20,000 - Existing capacity Q1FY19 Q3FY19 Q4FY19 Q2FY20 However, we have factored in gradual ramp up in volumes to factor in delay in stabilization of new capacities. November 29,

11 We have factored in gradual ramp-up of new capacities Rated capacity (MT) Production (MT) 120, , , ,000 80,000 73,315 68,705 82,446 60,000 40,000 55,000 55,000 49,967 44,415 54,964 20,000 - FY17 FY18 FY19 FY20 FY21 Sales growth to ride on higher volumes and increased realization Over FY14-18, Nocil s revenue growth CAGR of 12.9% has tracked the volume growth of 12.5%. This is because; realizations growth has been muted due to drop in crude oil prices. Going forward, we have factored in CAGR 5% realization growth over FY19-21E as crude prices have recovered from lows. This is in-line with crude inflationary realization growth over FY Also, supported by capacity additions coming on stream, we expect 24% CAGR revenue growth over FY18-21E. Have factored in net realization growth of 5% over FY18-21E Realisation (Rs/ton) Rs/ton FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19E FY20E FY21E Domestic market will continue to remain the bedrock Nocil s domestic share of sales has steadily increased to 74% in FY18 against 60% in FY10. This is on the back of intensely competitive export market in light of aggressive exports by Chinese players. However, recent clampdown on Chinese production capacities due to environmental factors will mean Nocil is better placed to cater to the export market. US has recently imposed 10% duty on imports from China and will impose another 15% from January This will open up opportunities for domestic players like Nocil to better target export market. Accordingly, we expect export share will increase to 31% in FY21E. However, domestic market will continue to remain the bedrock as domestic sales have increased at 18% CAGR over FY November 29,

12 Sales to increase at CAGR of 24% over FY18-21E (Rs mn) 20,000 18,000 16,000 14,000 12,000 10,000 8,000 6,000 4,000 2,000 - Domestic Exports Others FY14 FY15 FY16 FY17 FY18 FY19E FY20E FY21E Raw material cost intensity has come down Nocil s raw material price intensity has come down steadily over the years due to benign raw material prices and benefits of higher value added products. Accordingly, gross margins have expanded to 54.5% in FY18 against FY14 levels of 41.5%. We have factored in gross margins to remain stable at 54% for FY20/21E. Raw material prices have been benign for rubber chemicals players Source: China Sunsine, PL November 29,

13 Operating margins likely to remain elevated Nocil s operating profit margins have been on an uptrend led by product mix change, cost rationalization and operating leverage from improved volumes. Buoyed by margin improvement, operating profit margins have improved to 27.2% in FY18 against 21.3% in FY17 and 10.2% in FY14. With spreads likely to sustain in the medium term, we have factored in OPM of ~27% for FY19E; H1FY %. However, we have reduced our margins to 25% for FY20E to factor in removal of duty protection benefits by July Profits on an upswing Supported by healthy demand trend and margin expansion, Nocil s earnings have increased 3x to Rs1.7bn in FY18. With demand trend likely to remain robust, coupled with healthy operating leverage from new capacities, we expect Nocil s earnings to increase 21% over FY18-21E. Nocil s return ratios are likely to stay healthy supported by improved operating performance and lower finance charges. We calculate ROEs of ~17-20% over FY18-21E. Strong balance sheet - an added strength Nocil has a healthy balance sheet with net cash of Rs2.5bn as on FY18. Also, despite capex plans of Rs4.3bn over FY18-20E, steady cash flow from operations will mean a lean balance sheet. Nocil key assumptions FY15 FY16 FY17 FY18 FY19E FY20E FY21E Rubber chemicals sales (tons) 30,932 32,169 36,190 40,714 44,785 55,982 67,178 Realisation (Rs/ton) Sales (Rs m) 7,190 7,152 7,422 9,676 11,176 14,669 18,483 Gross profit (Rs m) 3,304 3,557 3,826 5,270 6,370 7,921 9,981 Gross profit (%) 46% 50% 52% 54% 57% 54% 54% EBIDTA 1,119 1,382 1,580 2,629 3,018 3,667 4,621 EBIDTA (%) 16% 19% 21% 27% 27% 25% 25% PAT ,165 1,689 1,808 2,371 2,968, Company, PL Nocil earnings sensitivity to realization and volume changes Base case Sensitivity FY20E earnings sensitivity (Rs m) Base case PAT Revised PAT % change 2% drop in EBIDTA margin due to anti-dumping Duty abolition Anti-Dumping Duty abolition of 4% 2,371 2,172-8% 5% increase in realization Zero increase in realization 2,371 2,260-5% FY20E volume growth of 25% FY20E volume growth of 15% 2,371 2,184-8% November 29,

14 Valuation Nocil s is expected to report 21% CAGR in earnings growth over FY18-21E led by 1) higher volumes post commissioning of new capacity 2) higher realisation and 3) benign raw material pricing. We have valued Nocil at 15x P/E FY21E which translates to EV/E of 8.0x FY21E. Chemicals Peer comparison valuation Price M Cap (USDm) P/E (x) EV/EBIDTA (x) RoE (%) FY19E FY20E FY21E FY19E FY20E FY21E FY19E FY20E FY21E AARTI INDUSTRIES LIMITED 1,455 1, ATUL LTD 3,486 1, SRF LTD 2,132 1, VINATI ORGANICS LTD 1,448 1, NAVIN FLUORINE CHINA SUNSINE na NOCIL AEKYUNG PETROCHEMICAL CO LTD 8, I.G. PETROCHEMICALS LTD Source: Bloomberg, PL Nocil's FY20E earnings sensitivity to margin changes Base case Nocil earnings sensitivity to margins 15% 20% 25% 30% 35% FY20E EPS Nocil earnings sensitivity to realization and volume changes Base case Sensitivity FY20E earnings sensitivity (Rs m) Base case PAT Revised PAT % change 2% drop in EBIDTA margin due to anti Dumping Duty abolition Anti Dumping Duty abolition of 4% 2,371 2,172-8% 5% increase in realization Zero increase in realization 2,371 2,260-5% FY20E volume growth of 25% FY20E volume growth of 15% 2,371 2,184-8% November 29,

15 Key risk to our call Threat of US-China trade war: In the event of flare up in US-China trade war, there is a possibility of Chinese volumes being diverted to India as US is world s second largest rubber chemical player after China. Delay in ramp up of new capacity: Nocil plans to double its capacity by H2FY20E, however, any delay in start and ramp up of new capacity will impact earnings. Sensitivity to lower production Base case Sensitivity Base case PAT(Rs m) Revised PAT(Rs m) % change FY20E production volume of ~69,000MT 20% lower volumes 2,371 1,903-20% Removal of anti-dumping duty: The anti-dumping duty imposed on rubber chemicals imports will end in July Duty protection adds to ~4% of operating profits. Management remains hopeful of extension of duty protection as Chinese companies with ~70% of global capacity and ~33% of usage has potential to injure domestic players. In the event of complete removal of duty protection, FY20E earnigs will be impacted by ~8% against our base case. November 29,

16 Story in charts Operating margins have steadily increased with H1FY19 margin of 29.5% Improving trends in operating margins EBIDTA EBIDTA margin (Rs mn) 5,000 4,000 3,000 2,000 1,000-27% 27% 25% 25% 21% 19% 1,382 1,580 2,629 3,018 3,667 4,621 FY16 FY17 FY18 FY19E FY20E FY21E 30% 25% 20% 15% 10% 5% 0% We expect FY18-21E PAT CAGR of 22% 3,500 3,000 Profit momentum is likely to remain robust 2,968 2,500 2,371 (Rs mn) 2,000 1,500 1,165 1,689 1,808 1, FY16 FY17 FY18 FY19E FY20E FY21E Source: Company Data, PL Return ratios to steadily increase for the company with rising profitability Return ratios are likely to remain robust ROE ROCE FY16 FY17 FY18 FY19E FY20E FY21E November 29,

17 Financials Income Statement (Rs m) Y/e Mar FY18 FY19E FY20E FY21E Net Revenues 9,676 11,176 14,669 18,483 YoY gr. (%) Cost of Goods Sold 4,406 4,806 6,748 8,502 Gross Profit 5,270 6,370 7,921 9,981 Margin (%) Employee Cost ,174 1,479 Other Expenses 1,968 2,459 3,080 3,881 EBITDA 2,629 3,018 3,667 4,621 YoY gr. (%) Margin (%) Depreciation and Amortization Balance Sheet Abstract (Rs m) Y/e Mar FY18 FY19E FY20E FY21E Non-Current Assets Gross Block 6,569 6,569 10,819 10,919 Tangibles 6,569 6,569 10,819 10,919 Intangibles Acc: Dep / Amortization 1,576 1,803 2,105 2,528 Tangibles 1,576 1,803 2,105 2,528 Intangibles Net fixed assets 4,994 4,766 8,715 8,391 Tangibles 4,994 4,766 8,715 8,391 Intangibles EBIT 2,400 2,790 3,366 4,197 Margin (%) Net Interest Other Income Capital Work In Progress 392 2, Goodwill Non-Current Investments Net Deferred tax assets (1,003) (1,277) (1,636) (2,086) Other Non-Current Assets Profit Before Tax 2,531 2,740 3,593 4,497 Margin (%) Total Tax ,222 1,529 Effective tax rate (%) Profit after tax 1,686 1,808 2,371 2,968 Minority interest Share Profit from Associate Adjusted PAT 1,689 1,808 2,371 2,968 YoY gr. (%) Margin (%) Extra Ord. Income / (Exp) Reported PAT 1,689 1,808 2,371 2,968 YoY gr. (%) Margin (%) Other Comprehensive Income Total Comprehensive Income 1,689 1,808 2,371 2,968 Equity Shares O/s (m) EPS (Rs) Source: Company Data, PL Research Current Assets Investments 2,245 2,245 2,245 2,245 Inventories 1,550 1,790 2,350 2,960 Trade receivables 2,434 2,811 3,689 4,648 Cash & Bank Balance Other Current Assets Total Assets 13,317 16,488 19,052 20,196 Equity Equity Share Capital 1,645 1,645 1,645 1,645 Other Equity 8,730 10,098 11,892 14,137 Total Networth 10,374 11,742 13,536 15,782 Non-Current Liabilities Long Term borrowings - 2,000 2,000 - Provisions Other non current liabilities Current Liabilities ST Debt / Current of LT Debt Trade payables 1,139 1,315 1,726 2,175 Other current liabilities Total Equity & Liabilities 13,322 16,488 19,052 20,196 Source: Company Data, PL Research November 29,

18 Cash Flow (Rs m) Y/e Mar FY18 FY19E FY20E FY21E Key Financial Metrics Year Y/e Mar FY18 FY19E FY20E FY21E PBT 2,531 2,740 3,593 4,497 Per Share(Rs) Add. Depreciation EPS Add. Interest CEPS Less Financial Other Income BVPS Add. Other (110) 640 (387) (460) FCF (3.0) 11.9 Op. profit before WC changes 2,685 3,608 3,507 4,461 DPS Net Changes-WC (899) (141) (1,027) (1,121) Return Ratio(%) Direct tax (802) (932) (1,222) (1,529) RoCE Net cash from Op. activities 984 2,535 1,259 1,810 ROIC Capital expenditures (276) (2,495) (1,750) 142 RoE Interest / Dividend Income Balance Sheet Others (1,133) Net Debt : Equity (x) (0.2) (0.1) 0.0 (0.2) Net Cash from Invt. activities (1,379) (1,544) (959) 1,118 Net Working Capital (Days) Issue of share cap. / premium Valuation(x) Debt changes (100) 2,000 - (2,000) PER Dividend paid (350) (526) (690) (864) P/B Interest paid (13) P/CEPS Others EV/EBITDA Net cash from Fin. activities (422) 1,474 (690) (2,864) EV/Sales Net change in cash (816) 2,465 (390) 64 Dividend Yield (%) Free Cash Flow (491) 1,952 Source: Company Data, PL Research Source: Company Data, PL Research Quarterly Financials (Rs m) Y/e Mar Q3FY18 Q4FY18 Q1FY19 Q2FY19 Net Revenue 2,493 2,759 2,681 2,720 YoY gr. (%) Raw Material Expenses 1,148 1,220 1,190 1,194 Gross Profit 1,344 1,539 1,491 1,526 Margin (%) EBITDA YoY gr. (%) (5.1) (1.7) Margin (%) Depreciation / Depletion EBIT Margin (%) Net Interest Other Income Profit before Tax Margin (%) Total Tax Effective tax rate (%) Profit after Tax Minority interest Share Profit from Associates Adjusted PAT YoY gr. (%) (9.7) 38.8 Margin (%) Extra Ord. Income / (Exp) Reported PAT YoY gr. (%) (9.7) 38.8 Margin (%) Other Comprehensive Income Total Comprehensive Income Avg. Shares O/s (m) EPS (Rs) Source: Company Data, PL Research November 29,

19 Analyst Coverage Universe NOCIL Sr. No. Company Name Rating TP (Rs) Share Price (Rs) 1 Bharat Petroleum Corporation Accumulate GAIL (India) BUY Hindustan Petroleum Corporation Hold I.G. Petrochemicals BUY Indian Oil Corporation Accumulate Indraprastha Gas BUY Mahanagar Gas BUY 1, NOCIL NR Oil & Natural Gas Corporation BUY Oil India Accumulate Petronet LNG BUY Reliance Industries Accumulate 1,152 1,122 PL s Recommendation Nomenclature (Absolute Performance) Buy : > 15% Accumulate : 5% to 15% Hold : +5% to -5% Reduce : -5% to -15% Sell : < -15% Not Rated (NR) : No specific call on the stock Under Review (UR) : Rating likely to change shortly November 29,

20 ANALYST CERTIFICATION (Indian Clients) We/I, Mr. Avishek Datta- MBA Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. (US Clients) The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report. DISCLAIMER Indian Clients Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as PL ) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document. PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014 PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities. PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company. PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report. PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report. PL or its associates might have received compensation from the subject company in the past twelve months. PL or its associates might have managed or co-managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months. PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months. PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report. PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report. It is confirmed that Mr. Avishek Datta- MBA Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest. PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. US Clients This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer. Prabhudas Lilladher Pvt. Ltd. 3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai , India Tel: (91 22) Fax: (91 22) Bloomberg Research Page: PRLD <GO> November 29,

Indian Oil Corporation (IOCL IN)

Indian Oil Corporation (IOCL IN) (IOCL IN) Rating: ACCUMULATE CMP: Rs148 TP: Rs142 November 2, 2018 Q2FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating ACCUMULATE ACCUMULATE

More information

Bayer Cropscience (BYRCS IN)

Bayer Cropscience (BYRCS IN) (BYRCS IN) Rating: ACCUMULATE CMP: Rs4,258 TP: Rs4,517 February 4, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating ACCUMULATE

More information

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276 Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276 October 26, 2018 Q2FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E

More information

FY20E FY21E FY20E FY21E

FY20E FY21E FY20E FY21E (SJET IN) Rating: BUY CMP: Rs80 TP: Rs107 February 12, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating BUY BUY Target Price

More information

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018 (BHEL IN) Rating: REDUCE CMP: Rs72 TP: Rs73 July 25, 2018 Q1FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating REDUCE REDUCE Target Price

More information

Mahanagar Gas (MAHGL IN)

Mahanagar Gas (MAHGL IN) (MAHGL IN) Rating: BUY CMP: Rs947 TP: Rs1,179 August 1, 2018 Q1FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target Price

More information

Larsen & Toubro (LT IN)

Larsen & Toubro (LT IN) (LT IN) Rating: BUY CMP: Rs1,321 TP: Rs1,566 July 25, 2018 Company Report Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target Price 1,566

More information

Petronet LNG (PLNG IN)

Petronet LNG (PLNG IN) (PLNG IN) Rating: BUY CMP: Rs231 TP: Rs300 July 27, 2018 Q1FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target Price 300

More information

Bharat Electronics (BHE IN)

Bharat Electronics (BHE IN) (BHE IN) Rating: BUY CMP: Rs116 TP: Rs150 August 01, 2018 Q1FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target Price 150

More information

Bharat Petroleum Corporation

Bharat Petroleum Corporation Higher inventory loss drag earnings August 14, 2017 Avishek Datta avishekdatta@plindia.com +91 22 66322254 Rating BUY Price Rs479 Target Price Rs553 Implied Upside 15.4% Sensex 31,449 Nifty 9,794 (Prices

More information

KEC International (KECI IN)

KEC International (KECI IN) (KECI IN) Rating: BUY CMP: Rs370 TP: Rs425 June 15, 2018 Analyst Meet Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY - Target Price 425 -

More information

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research Healthy operating performance; Accumulate October 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs5,860 Target Price Rs6,356 Implied Upside 8.5% Sensex 27,916 Nifty

More information

Indraprastha Gas. Growth traction continues. Source: Company Data; PL Research

Indraprastha Gas. Growth traction continues. Source: Company Data; PL Research Growth traction continues June 28, 216 Avishek Datta avishekdatta@plindia.com +91 22 66322254 Rating BUY Price Rs65 Target Price Rs632 Implied Upside 4.5% Sensex 26,43 Nifty 8,95 (Prices as on June 27,

More information

Zee Media Corporation (ZEEN IN)

Zee Media Corporation (ZEEN IN) (ZEEN IN) Rating: BUY CMP: Rs26 TP: Rs39 October 17, 2018 Q2FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target Price 39

More information

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research Growth/margin bottoming May 25, 2018 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs704 Target Price Rs928 Implied Upside 31.8%

More information

Mahindra & Mahindra. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research Tractors drive Q2 performance; Accumulate November 11, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs1,242 Target Price Rs1,503 Implied Upside 21.0% Sensex 26,819 Nifty

More information

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research Exports remain subdued, outlook better November 08, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating BUY Price Rs850 Target Price Rs957 Implied Upside 12.6% Sensex 27,591 Nifty 8,544 (Prices

More information

TVS Motors. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research Margins trajectory looking up ; Accumulate November 01, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs709

More information

Maruti Suzuki (MSIL IN)

Maruti Suzuki (MSIL IN) (MSIL IN) Rating: BUY CMP: Rs6,513 TP: Rs7,600 January 28, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating BUY BUY Target Price

More information

Thermax. Source: Company Data; PL Research

Thermax. Source: Company Data; PL Research Near term outlook muted, working on building a strong base November 11, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price

More information

Cummins India. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research Technology leadership, cost optimization key focus October 28, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs852

More information

Rallis India (RALI IN)

Rallis India (RALI IN) (RALI IN) Rating: BUY CMP: Rs164 TP: Rs242 January 18, 2019 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating BUY BUY Target Price 242 242

More information

TVS Motors (TVSL IN)

TVS Motors (TVSL IN) (TVSL IN) Rating: ACCUMULATE CMP: Rs535 TP: Rs618 October 23, 2018 Q2FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating ACCUMULATE ACCUMULATE

More information

Tata Steel (TATA IN)

Tata Steel (TATA IN) (TATA IN) Rating: BUY CMP: Rs568 TP: Rs815 July 2, 2018 Event Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY17E FY18E Rating BUY BUY Target Price 815 830 Sales

More information

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research Run continues, Royalty reduction positive ; Buy January 29, 2018 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs9,277

More information

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research Healthy operating performance in Q2 November 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating BUY Price Rs65 Target Price Rs115 Implied Upside 76.9% Sensex 26,316 Nifty 8,114 (Prices

More information

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research Railways and T&D driving inflows November 23, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs1,055 Target Price Rs1,230

More information

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research Misses estimates; Higher costs dims hope for earnings recovery February 13, 2017 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Rating Reduce Price Rs325 Target Price Rs320 Implied Upside 1.5%

More information

Asian Paints. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research Premium valuations to sustain, Accumulate October 4, 17 Amnish Aggarwal amnishaggarwal@plindia.com +91 Gaurav Jogani gauravjogani@plindia.com +91 8 Rating Accumulate Price Rs1,1 Target Price Rs1,9 Implied

More information

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research Increased confidence on margins July 25, 2016 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Rating BUY Price Rs540 Target Price Rs570 Implied Upside 5.6% Sensex 28,095 Nifty 8,636 (Prices as

More information

Allcargo Logistics. Source: Company Data; PL Research

Allcargo Logistics. Source: Company Data; PL Research Slow capex continue to impact PES, weak show continues May 24, 2018 Keyur Pandya keyurpandya@plindia.com +912266322247 R Sreesankar rsreesankar@plindia.com +912266322214 Rating Accumulate Price Rs120 Target

More information

Heidelberg Cement India (HEIM IN)

Heidelberg Cement India (HEIM IN) (HEIM IN) Rating: BUY CMP: Rs159 TP: Rs200 July 31, 2018 Q1FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target Price 200

More information

Ambuja Cement (ACEM IN)

Ambuja Cement (ACEM IN) (ACEM IN) Rating: HOLD CMP: Rs201 TP: Rs210 October 24, 2018 Q3CY18 Result Update Change in Estimates Target Reco Change in Estimates Current Previous CY18E CY19E CY18E CY19E Rating HOLD ACCUMULATE Target

More information

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research Looking to exit overseas Power segment! May 29, 2015 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs166 Target Price Rs204

More information

Source: Company Data; PL Research

Source: Company Data; PL Research Strong inflow growth, renewable/railways key drivers October 28, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs1,063

More information

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840 (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840 July 20, 2018 Q1FY19 Result Update Continued improvement in biz yielding results Quick Pointers Company focuses to grow in protection (both segments) and

More information

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research In a league of its own ; Buy October 28, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs8,115 Target Price Rs9,250

More information

Eicher Motors. Continues to ride high! Accumulate. Source: Company Data; PL Research

Eicher Motors. Continues to ride high! Accumulate. Source: Company Data; PL Research Continues to ride high! Accumulate November 14, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs30,083 Target

More information

JK Lakshmi Cement. Source: Company Data; PL Research

JK Lakshmi Cement. Source: Company Data; PL Research Expansions on schedule; lower costs to aid margins June 28, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating BUY Price Rs385 Target

More information

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research Realisations drive the beat; E auction to surprise positively in H2 November 13, 2015 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating BUY

More information

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research Earnings marred by weak realisations; Downgrade to Accumulate September 14, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating Accumulate

More information

Reliance Industries. Impressive performance. Source: Company Data; PL Research

Reliance Industries. Impressive performance. Source: Company Data; PL Research Impressive performance April 25, 2017 Avishek Datta avishekdatta@plindia.com +91 22 66322254 Rating Accumulate Price Rs1,416 Target Price Rs1,343 Implied Upside 5.2% Sensex 29,656 Nifty 9,218 (Prices as

More information

Asian Paints. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research Premium Valuations to sustain, Accumulate May, 17 Amnish Aggarwal amnishaggarwal@plindia.com +91 Gaurav Jogani gauravjogani@plindia.com +91 8 Rating Accumulate Price Rs1,18 Target Price Rs1,171 Implied

More information

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research Lower costs and higher scale off sets weaker realisations February 12, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating BUY Price Rs305

More information

Britannia Industries

Britannia Industries Sustains momentum; Input cost gains peaked out November 09, 2015 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating Accumulate Price

More information

Wipro (WPRO IN) Solid revenue beat, BFSI remains strong. Q2FY19 Result Update. Rating: ACCUMULATE CMP: Rs309 TP: Rs350.

Wipro (WPRO IN) Solid revenue beat, BFSI remains strong. Q2FY19 Result Update. Rating: ACCUMULATE CMP: Rs309 TP: Rs350. (WPRO IN) Rating: ACCUMULATE CMP: Rs309 TP: Rs350 October 24, 2018 Q2FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating ACCUMULATE HOLD

More information

Ashok Leyland. Source: Company Data; PL Research

Ashok Leyland. Source: Company Data; PL Research Short term headwinds, structural story intact; Accumulate November 09, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate

More information

HDFC Standard Life Insurance

HDFC Standard Life Insurance Decent performance on all fronts January 21, 2018 Vidhi Shah vidhishah@plindia.com / +91 22 66322258 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22

More information

Coal India (COAL IN)

Coal India (COAL IN) Coal India (COAL IN) Rating: BUY CMP: Rs279 TP: Rs340 August 13, 2018 Q1FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target

More information

Bharat Electronics. Best defence play. Source: Company Data; PL Research

Bharat Electronics. Best defence play. Source: Company Data; PL Research Best defence play October 31, 2017 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs185 Target Price Rs219 Implied Upside 18.4%

More information

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research Growth led by Enterprise Retain BUY October 26, 20 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Hussain Kagzi hussainkagzi@plindia.com +91 22 66322242 Rating BUY Price Rs669 Target Price Rs780

More information

Hindustan Zinc. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research Beat on all counts; tight supplies to keep the Zinc prices firm October 20, 2015 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating BUY Price

More information

Hindustan Zinc. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research Earnings in line; best placed in the base metal pack July 21, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating Accumulate Price Rs193

More information

Avenue Supermarts (DMART IN)

Avenue Supermarts (DMART IN) (DMART IN) Rating: REDUCE CMP: Rs1,572 TP: Rs1,270 January 14, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating REDUCE REDUCE

More information

Bharat Forge. Growth on all fronts; Accumulate. Source: Company Data; PL Research

Bharat Forge. Growth on all fronts; Accumulate. Source: Company Data; PL Research Growth on all fronts; Accumulate November 08, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs728 Target Price

More information

Crompton Greaves Consumer Electricals

Crompton Greaves Consumer Electricals Building strong base for growth May 16, 2018 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs228 Target Price Rs299 Implied

More information

Titan Company (TTAN IN)

Titan Company (TTAN IN) (TTAN IN) Rating: BUY CMP: Rs992 TP: Rs1,195 February 1, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating BUY BUY Target Price

More information

Ultratech Cement. Source: Company Data; PL Research

Ultratech Cement. Source: Company Data; PL Research Higher realisations drove the show; Price led recovery still away April 25, 2018 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Amit Khimesra amitkhimesra@plindia.com +91 22 66322244 Rating Accumulate

More information

Tata Steel (TATA IN)

Tata Steel (TATA IN) Tata Steel (TATA IN) Rating: BUY CMP: Rs560 TP: Rs780 October 3, 2018 Meeting Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target Price

More information

Navneet Education. ILL loss hurts consolidated earnings growth. Source: Company Data; PL Research

Navneet Education. ILL loss hurts consolidated earnings growth. Source: Company Data; PL Research ILL loss hurts consolidated earnings growth May 14, 2018 Keyur Pandya keyurpandya@plindia.com +91 22 66322247 R Sreesankar rsreesankar@plindia.com +91 22 66322214 Rating Accumulate Price Rs140 Target Price

More information

Tata Motors. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research Good show...but tread carefully ; Accumulate November 09, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs440

More information

Reliance Industries (RIL IN)

Reliance Industries (RIL IN) (RIL IN) Rating: ACCUMULATE CMP: Rs1,134 TP: Rs1,238 January 18, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating ACCU MUL ATE

More information

Voltas (VOLT IN) Delicately poised ahead of summer season. Q3FY19 Reuslt Update. Rating: ACCUMULATE CMP: Rs522 TP: Rs600.

Voltas (VOLT IN) Delicately poised ahead of summer season. Q3FY19 Reuslt Update. Rating: ACCUMULATE CMP: Rs522 TP: Rs600. (VOLT IN) Rating: ACCUMULATE CMP: Rs522 TP: Rs600 February 15, 2019 Q3FY19 Reuslt Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating ACCUMULATE ACCUMULATE

More information

Coal India (COAL IN)

Coal India (COAL IN) Coal India (COAL IN) Rating: HOLD CMP: Rs248 TP: Rs270 December 26, 2018 Company Report Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating HOLD BUY Target

More information

Dr. Lal PathLabs. Source: Company Data; PL Research

Dr. Lal PathLabs. Source: Company Data; PL Research Operating efficiency, Seasonal tailwind lead growth, margin November 09, 2017 Surajit Pal surajitpal@plindia.com +91 22 66322259 Rating Accumulate Price Rs832 Target Price Rs963 Implied Upside 15.7% Sensex

More information

Larsen & Toubro. Decent performance! Source: Company Data; PL Research

Larsen & Toubro. Decent performance! Source: Company Data; PL Research Decent performance! July 30, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating BUY Price Rs1,558 Target Price Rs1,590 Implied Upside 2.1%

More information

Indraprastha Gas. Source: Company Data; PL Research

Indraprastha Gas. Source: Company Data; PL Research MNGL on an accelerated growth trajectory August 29, 2016 Avishek Datta avishekdatta@plindia.com +91 22 66322254 Rating Accumulate Price Rs784 Target Price Rs725 Implied Upside 7.5% Sensex 27,782 Nifty

More information

Hindalco Industries. Source: Company Data; PL Research

Hindalco Industries. Source: Company Data; PL Research Beats its own best; building up for next leg of growth May 08, 2018 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Amit Khimesra amitkhimesra@plindia.com +91 22 66322244 Rating BUY Price Rs239

More information

Tata Motors. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research JLR margin disappoints, Standalone turning around; Accumulate February 06, 2018 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate

More information

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research Strong growth, reasonable valuations August 16, 2017 Madhu Babu madhubabu@plindia.com +91 22 66322300 Rating BUY Price Rs160 Target Price Rs200 Implied Upside 25.0% Sensex 31,771 Nifty 9,897 (Prices as

More information

Jindal Steel & Power

Jindal Steel & Power Good show in tough environment; well placed for long term BUY May 05, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating Accumulate Price

More information

Va Tech Wabag. On track for a strong H2FY16. Source: Company Data; PL Research

Va Tech Wabag. On track for a strong H2FY16. Source: Company Data; PL Research On track for a strong H2FY16 November 09, 2015 Nishna Biyani nishnabiyani@plindia.com +91 22 66322239 Keyur Pandya keyurpandya@plindia.com +91 22 +91 22 66322247 Rating BUY Price Rs668 Target Price Rs1,000

More information

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research Strong growth in core services October 19, 2015 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Hussain Kagzi hussainkagzi@plindia.com +91 22 66322242 Rating BUY Price Rs494 Target Price Rs625

More information

Eicher Motors. Source: Company Data; PL Research

Eicher Motors. Source: Company Data; PL Research Good show continues; In line quarter! Accumulate May 09, 2018 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs30,305

More information

LIC Housing Finance. Source: Company Data; PL Research

LIC Housing Finance. Source: Company Data; PL Research High prepayment remains a drag; earnings momentum to sustain April 20, 2016 Nitin Kumar nitinkumar@plindia.com / +91 22 66322236 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com

More information

ICICI Prudential Life Insurance

ICICI Prudential Life Insurance Margins were positive surprise; APE growth was slow January 21, 2018 Vidhi Shah vidhishah@plindia.com / +91 22 66322258 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com

More information

Mphasis. Source: Company Data; PL Research

Mphasis. Source: Company Data; PL Research Setting path for growth in Direct Channel, Retain Accumulate June 18, 2015 Shashi Bhusan shashibhusan@plindia.com +91 22 66322300 Hussain Kagzi hussainkagzi@plindia.com +91 22 66322242 Rating Accumulate

More information

Tech Mahindra. Source: Company Data; PL Research

Tech Mahindra. Source: Company Data; PL Research Margin beat driven by Headcount reduction November 01, 2017 Madhu Babu madhubabu@plindia.com +91 22 66322300 Rating BUY Price Rs489 Target Price Rs535 Implied Upside 9.4% Sensex 33,600 Nifty 10,441 (Prices

More information

Future Retail (FRETAIL IN)

Future Retail (FRETAIL IN) (FRETAIL IN) Rating: BUY CMP: Rs448 TP: Rs576 February 4, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating BUY BUY Target Price

More information

Aurobindo Pharma. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research Sales miss on few approvals, earnings beats on better revenue May 31, 2016 Surajit Pal surajitpal@plindia.com +912266322259 Rating BUY Price Rs786 Target Price Rs943 Implied Upside 2% Sensex 26,668 Nifty

More information

Cummins India. Focusing on growth in core segments. Source: Company Data; PL Research

Cummins India. Focusing on growth in core segments. Source: Company Data; PL Research Focusing on growth in core segments June 07, 2018 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs681 Target Price Rs857 Implied

More information

Cadila Healthcare. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research Q4 broadly in line; US remain cornerstone of growth May 26, 2018 Surajit Pal surajitpal@plindia.com +912266322259 Rating Accumulate Price Rs383 Target Price Rs438 Implied Upside 14.4% Sensex 34,925 Nifty

More information

S Chand and Company. TP of Rs679 (implying PER of 20x FY19E earnings) Source: Company Data; PL Research

S Chand and Company. TP of Rs679 (implying PER of 20x FY19E earnings) Source: Company Data; PL Research 2Q is a non event, annual guidance remains intact November 20, 2017 Keyur Pandya keyurpandya@plindia.com +912266322247 R Sreesankar rsreesankar@plindia.com +912266322214 Rating BUY Price Rs461 Target Price

More information

Punjab National Bank

Punjab National Bank Slippages remain high despite high recoveries May 22, 2017 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com

More information

Hexaware Technologies (HEXW IN)

Hexaware Technologies (HEXW IN) (HEXW IN) Rating: ACCUMULATE CMP: Rs351 TP: Rs430 October 24, 2018 Q3CY18 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating ACCUMULATE HOLD

More information

Hindustan Unilever. In the Pink of Health ; Accumulate. Source: Company Data; PL Research

Hindustan Unilever. In the Pink of Health ; Accumulate. Source: Company Data; PL Research In the Pink of Health ; Accumulate May 14, 2018 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Nishita Doshi nishitadoshi@plindia.com +91 22 66322381 Rating Accumulate Price Rs1,505 Target

More information

Jindal Steel & Power

Jindal Steel & Power Angul plant s Turnaround, a reality now; Reiterate BUY January 22, 2018 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Amit Khimesra amitkhimesra@plindia.com +91 22 66322244 Rating BUY Price

More information

Crompton Greaves Consumer Electricals

Crompton Greaves Consumer Electricals Enough headroom for growth in core categories February 20, 2018 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs232 Target Price

More information

Punjab National Bank

Punjab National Bank Steady on all fronts February 07, 2018 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com / +91 22 66322258 Rating

More information

IDEA RESEARCH. Q2FY19 Result Update Tuesday, November 13, Mold Tek Packaging Lower gross margins & higher interest cost impacts profitability

IDEA RESEARCH. Q2FY19 Result Update Tuesday, November 13, Mold Tek Packaging Lower gross margins & higher interest cost impacts profitability (MTEP) reported Q2 results, slightly below expectations. Cons. net sales grew by 27.1% YoY but were marginally lower sequentially to Rs 1,005m. Q2 is a seasonally weak quarter (Q1 and Q4 being stronger).

More information

Source: Company Data; PL Research

Source: Company Data; PL Research Valuations attractive, GST key to re rating : BUY January 20, 2018 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Nishita Doshi nishitadoshi@plindia.com +91 22 66322381 Rating BUY Price Rs274

More information

HDFC Standard Life Insurance Company (HDFCLIFE IN ) Rating: BUY CMP: Rs359 TP: Rs500

HDFC Standard Life Insurance Company (HDFCLIFE IN ) Rating: BUY CMP: Rs359 TP: Rs500 HDFC Standard Life Insurance Company (HDFCLIFE IN ) Rating: BUY CMP: Rs359 TP: Rs500 October 24, 2018 Q2FY19 Result Update Margins on rise mainly led by protection biz Quick Pointers Protection share has

More information

Capital First. Continuing to grow strong. Source: Company Data; PL Research

Capital First. Continuing to grow strong. Source: Company Data; PL Research Continuing to grow strong May 07, 2018 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Shweta Daptardar shwetadaptardar@plindia.com / +91 22

More information

Larsen & Toubro. Source: Company Data; PL Research

Larsen & Toubro. Source: Company Data; PL Research Domestic execution showing positive trends July 28, 2017 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Rating BUY Price Rs1,159 Target Price Rs1,328 Implied Upside 14.6% Sensex 32,310 Nifty 10,015

More information

LIC Housing Finance. Stable performance. Source: Company Data; PL Research

LIC Housing Finance. Stable performance. Source: Company Data; PL Research Stable performance October 21, 2016 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com / +91 22 66322258 Rating

More information

Colgate Palmolive. Source: Company Data; PL Research

Colgate Palmolive. Source: Company Data; PL Research 6 8% EPS cut as competitive threat looms large May 24, 2016 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating Accumulate Price Rs835

More information

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs620 TP: Rs779

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs620 TP: Rs779 (SBILIFE IN ) Rating: BUY CMP: Rs620 TP: Rs779 January 18, 2019 Q3FY19 Result Update Strong growth with steady metrics Quick Pointers Strong growth displayed in protection business with +4x growth YoY

More information

Mphasis (MPHL IN) Modest Revenue and margin miss. Q2FY19 Result Update. Rating: ACCUMULATE CMP: Rs1,068 TP: Rs1,220.

Mphasis (MPHL IN) Modest Revenue and margin miss. Q2FY19 Result Update. Rating: ACCUMULATE CMP: Rs1,068 TP: Rs1,220. (MPHL IN) Rating: ACCUMULATE CMP: Rs1,068 TP: Rs1,220 October 21, 2018 Q2FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating ACCUMULATE

More information

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Costcontrol does the wonder, beat est; Consistency required November 03, 2017 Surajit Pal surajitpal@plindia.com +912266322259 Rating Accumulate Price Rs627 Target Price Rs733 Implied Upside 16.9% Sensex

More information

Persistent Systems (PSYS IN)

Persistent Systems (PSYS IN) (PSYS IN) Rating: ACCUMULATE CMP: Rs560 TP: Rs725 October 22, 2018 Q2FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating ACCUMULATE ACCUMULATE

More information